Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.78
|
0.84
|
0.79
|
0.7701
|
0.802
|
0.801899
|
|
|
13 331.83
|
113.00
|
0.7901
|
0.85
|
0.8549
|
0.77
|
0.8549
|
0.79
|
|
|
44 965.32
|
168.00
|
0.7898
|
0.8483
|
0.79
|
0.78
|
0.82
|
0.79
|
|
|
39 922.33
|
162.00
|
0.7803
|
0.8199
|
0.80
|
0.751
|
0.84
|
0.81
|
|
|
51 489.19
|
255.00
|
0.7801
|
0.95
|
0.761
|
0.761
|
0.83
|
0.7909
|
|
|
73 117.45
|
485.00
|
0.76
|
0.80
|
0.8805
|
0.70
|
0.914
|
0.761
|
|
|
80 030.35
|
477.00
|
0.8303
|
0.92
|
0.8802
|
0.86
|
0.90
|
0.885
|
|
|
22 101.31
|
157.00
|
0.89
|
0.9889
|
0.92
|
0.86
|
0.93
|
0.888
|
|
|
46 823.63
|
198.00
|
0.931
|
1.00
|
0.875
|
0.82
|
0.9236
|
0.8867
|
|
|
106 762.27
|
431.00
|
0.8707
|
0.99
|
0.9819
|
0.87
|
1.0399
|
0.8707
|
|
|
112 753.69
|
504.00
|
Cingulate Inc. operates as a clinical stage biopharmaceutical company. The Company develops pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.